CLDN4 and invasive ductal breast carcinoma: Abd-Elazeem et al. investigated CLDN4 overexpression in TNBC patients with primary invasive ductal carcinoma, identifying a positive and significant correlation with age, tumor size, grade, lymph node involvement, metastasis, and Ki-67 expression (20).